MX2018013471A - Nuevos compuestos de tipo tetrahidropirimidodiazepina y dihidropiridodiazepina para tratar el dolor y afecciones relacionadas con el dolor. - Google Patents
Nuevos compuestos de tipo tetrahidropirimidodiazepina y dihidropiridodiazepina para tratar el dolor y afecciones relacionadas con el dolor.Info
- Publication number
- MX2018013471A MX2018013471A MX2018013471A MX2018013471A MX2018013471A MX 2018013471 A MX2018013471 A MX 2018013471A MX 2018013471 A MX2018013471 A MX 2018013471A MX 2018013471 A MX2018013471 A MX 2018013471A MX 2018013471 A MX2018013471 A MX 2018013471A
- Authority
- MX
- Mexico
- Prior art keywords
- pain
- compounds
- subunit
- voltage
- tetrahydropyrimidodiazepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La presente invención se refiere a compuestos nuevos de fórmula general (I) que muestran una gran afinidad y actividad respecto a la subunidad a2d de los canales de calcio dependientes de voltaje (VGCC), especialmente la subunidad a2d-1 de los canales de calcio dependientes de voltaje, o una actividad dual respecto a la subunidad a2d de los canales de calcio dependientes de voltaje (VGCC), especialmente la subunidad a2d-1 de los canales de calcio dependientes de voltaje, y el transportador de noradrenalina (NET). La invención también se refiere al proceso para la preparación de dichos compuestos, así como también a las composiciones que los comprenden y su uso como medicamentos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16382199 | 2016-05-06 | ||
PCT/EP2017/060780 WO2017191304A1 (en) | 2016-05-06 | 2017-05-05 | Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018013471A true MX2018013471A (es) | 2019-06-06 |
Family
ID=56024209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018013471A MX2018013471A (es) | 2016-05-06 | 2017-05-05 | Nuevos compuestos de tipo tetrahidropirimidodiazepina y dihidropiridodiazepina para tratar el dolor y afecciones relacionadas con el dolor. |
Country Status (32)
Country | Link |
---|---|
US (1) | US10590140B2 (es) |
EP (1) | EP3452475B1 (es) |
JP (1) | JP6926197B2 (es) |
KR (1) | KR20190024876A (es) |
CN (1) | CN109526220B (es) |
AR (1) | AR108387A1 (es) |
AU (1) | AU2017260305B2 (es) |
BR (1) | BR112018072755A2 (es) |
CA (1) | CA3023379A1 (es) |
CO (1) | CO2018012002A2 (es) |
CY (1) | CY1123231T1 (es) |
DK (1) | DK3452475T3 (es) |
ES (1) | ES2789676T3 (es) |
HR (1) | HRP20200668T1 (es) |
HU (1) | HUE051829T2 (es) |
IL (1) | IL262825A (es) |
LT (1) | LT3452475T (es) |
ME (1) | ME03726B (es) |
MX (1) | MX2018013471A (es) |
MY (1) | MY196791A (es) |
PH (1) | PH12018502337A1 (es) |
PL (1) | PL3452475T3 (es) |
PT (1) | PT3452475T (es) |
RS (1) | RS60528B1 (es) |
RU (1) | RU2018141084A (es) |
SG (1) | SG11201809799WA (es) |
SI (1) | SI3452475T1 (es) |
TN (1) | TN2018000372A1 (es) |
TW (1) | TWI736619B (es) |
UA (1) | UA123789C2 (es) |
WO (1) | WO2017191304A1 (es) |
ZA (1) | ZA201807653B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019076904A1 (en) * | 2017-10-16 | 2019-04-25 | Esteve Pharmaceuticals, S.A. | PROPANAMINE DERIVATIVES FOR THE TREATMENT OF PAIN AND PAIN DISEASES ASSOCIATED WITH PAIN |
SG11202003599UA (en) * | 2017-10-27 | 2020-05-28 | Esteve Pharmaceuticals Sa | New alcoxyamino derivatives for treating pain and pain related conditions |
WO2019110137A1 (en) * | 2017-12-04 | 2019-06-13 | Esteve Pharmaceuticals, S.A. | O-phenoxy and o-benzyloxypropylamino derivatives having activity against pain |
WO2019115008A1 (en) * | 2017-12-12 | 2019-06-20 | Esteve Pharmaceuticals, S.A. | Dialkylaminoarylpiperidinyl-o-phenoxy and o-benzyloxypropylamino derivatives having multimodal activity against pain |
WO2019149919A1 (en) * | 2018-02-05 | 2019-08-08 | Esteve Pharmaceuticals, S.A. | Aminopropoxypiperidinylamido derivatives having multimodal activity against pain |
WO2020089263A1 (en) * | 2018-10-31 | 2020-05-07 | Esteve Pharmaceuticals, S.A. | Optionally nitrogenated isoquinolin-1(2h)-ones and 1h-isochromen- 1-ones for treating pain and pain related conditions |
TW202031264A (zh) * | 2018-11-02 | 2020-09-01 | 西班牙商埃斯特維製藥公司 | 用於治療疼痛和疼痛相關疾病的新穎烷氧基氨基吡啶衍生物 |
WO2020089478A1 (en) * | 2018-11-02 | 2020-05-07 | Esteve Pharmaceuticals, S.A. | New tetrahydropyrimidodiazepin and tetrahydropyridodiazepin compounds for treating pain and pain related conditions |
US20220204481A1 (en) * | 2019-02-28 | 2022-06-30 | Osaka University | Protein and/or peptide modification molecule |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU9224101A (en) * | 2000-09-27 | 2002-04-08 | Ajinomoto Kk | Benzodiazepine derivative |
CA2488566A1 (en) | 2002-06-27 | 2004-01-08 | Warner-Lambert Company Llc | Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder |
EP1724264A1 (en) * | 2004-03-10 | 2006-11-22 | Ono Pharmaceutical Co., Ltd. | Nitriles and medicinal compositions containing the same as the active ingredient |
ZA200806871B (en) * | 2006-02-14 | 2009-10-28 | Vertex Pharma | Dihydrodiazepines useful as inhibitors of protein kinases |
TW200914457A (en) | 2007-05-31 | 2009-04-01 | Kyowa Hakko Kogyo Kk | Pyrimidodiazepinone derivative |
UY32622A (es) * | 2009-05-12 | 2010-12-31 | Astrazeneca Ab | Nuevos compuestos para el tratamiento de patologías relacionadas con ab(beta) |
-
2017
- 2017-05-05 TW TW106114980A patent/TWI736619B/zh not_active IP Right Cessation
- 2017-05-05 DK DK17721680.1T patent/DK3452475T3/da active
- 2017-05-05 KR KR1020187032195A patent/KR20190024876A/ko not_active Application Discontinuation
- 2017-05-05 CA CA3023379A patent/CA3023379A1/en not_active Abandoned
- 2017-05-05 JP JP2019510471A patent/JP6926197B2/ja active Active
- 2017-05-05 SI SI201730239T patent/SI3452475T1/sl unknown
- 2017-05-05 RS RS20200595A patent/RS60528B1/sr unknown
- 2017-05-05 LT LTEP17721680.1T patent/LT3452475T/lt unknown
- 2017-05-05 PT PT177216801T patent/PT3452475T/pt unknown
- 2017-05-05 EP EP17721680.1A patent/EP3452475B1/en active Active
- 2017-05-05 HU HUE17721680A patent/HUE051829T2/hu unknown
- 2017-05-05 MX MX2018013471A patent/MX2018013471A/es unknown
- 2017-05-05 MY MYPI2018704135A patent/MY196791A/en unknown
- 2017-05-05 AU AU2017260305A patent/AU2017260305B2/en not_active Ceased
- 2017-05-05 ME MEP-2020-101A patent/ME03726B/me unknown
- 2017-05-05 TN TNP/2018/000372A patent/TN2018000372A1/en unknown
- 2017-05-05 WO PCT/EP2017/060780 patent/WO2017191304A1/en unknown
- 2017-05-05 CN CN201780042378.XA patent/CN109526220B/zh active Active
- 2017-05-05 SG SG11201809799WA patent/SG11201809799WA/en unknown
- 2017-05-05 US US16/098,244 patent/US10590140B2/en active Active
- 2017-05-05 BR BR112018072755-5A patent/BR112018072755A2/pt not_active IP Right Cessation
- 2017-05-05 PL PL17721680T patent/PL3452475T3/pl unknown
- 2017-05-05 RU RU2018141084A patent/RU2018141084A/ru unknown
- 2017-05-05 UA UAA201811326A patent/UA123789C2/uk unknown
- 2017-05-05 AR ARP170101172A patent/AR108387A1/es unknown
- 2017-05-05 ES ES17721680T patent/ES2789676T3/es active Active
-
2018
- 2018-11-06 PH PH12018502337A patent/PH12018502337A1/en unknown
- 2018-11-06 IL IL262825A patent/IL262825A/en unknown
- 2018-11-14 ZA ZA2018/07653A patent/ZA201807653B/en unknown
- 2018-11-29 CO CONC2018/0012002A patent/CO2018012002A2/es unknown
-
2020
- 2020-04-26 HR HRP20200668TT patent/HRP20200668T1/hr unknown
- 2020-05-25 CY CY20201100472T patent/CY1123231T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018502337A1 (en) | Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions | |
PH12017501921A1 (en) | Novel compounds | |
PH12020550901A1 (en) | Macrocyclic compounds for treating disease | |
MX2019002356A (es) | Compuestos de biarilo utiles como inmunomoduladores. | |
MY195427A (en) | Jak Kinase Inhibitor Compounds for Treatment of Respiratory Disease | |
PH12019501985A1 (en) | Fused imidazo-piperidine jak inhibitors | |
IL288278A (en) | Alternative 1-oxo-isoindolin-5-carboxamide compounds, compounds thereof, and methods of treatment therewith | |
PH12017501669A1 (en) | Alpha-cinnamide compounds and compositions as hdac8 inhibitors | |
PH12015502414A1 (en) | Enhancer of zeste homolog 2 inhibitors | |
MX2020006237A (es) | Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4. | |
PH12019502363A1 (en) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds | |
MX2017014035A (es) | Formas solidas novedosas. | |
MY197440A (en) | Heteroamatic compounds as btk inhibitors | |
MX2019013808A (es) | Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cancer. | |
EA201991580A1 (ru) | Пиримидиновое соединение и его фармацевтическое применение | |
MX2018000419A (es) | Derivados de amida sustituida que tienen actividad multimodal contra el dolor. | |
EA201890449A1 (ru) | Фумагиллиновые гетероциклические соединения и способы их получения и применения | |
MX2019006863A (es) | Inhibidores de heparanasa y uso de los mismos. | |
EA201692260A1 (ru) | Соединения 1,3,4-тиадиазола и их применение в лечении рака | |
EA201790070A1 (ru) | Бифениламиды, содержащие модифицированные простые эфирные группы, в качестве ингибиторов hsp90 и стимуляторов hsp70 | |
PH12020550594A1 (en) | New alcoxyamino derivatives for treating pain and pain related conditions | |
MX2018007517A (es) | Compuestos triciclicos y composiciones como inhibidores de quinasa. | |
MX2017014752A (es) | Nuevos etinos de amidoheteroaril aroil hidrazida. | |
MX2016004094A (es) | Composicion farmaceutica que comprende capecitabina y ciclofosfamida. | |
PH12018500682A1 (en) | Oxa-diazaspiro compounds having activity against pain |